Zhang, H., Zheng, H., Wang, Y., Chen, C., Tong, Y., Xie, S., Ma, X., Guo, L., Lu, R.

Background
Anti-programmed cell death protein 1 (anti-PD-1) antibodies have achieved revolutionary success in cancer therapy. However, the impact of anti-PD-1 therapy on host humoral immunity in humans during cancer immunotherapy requires further inve…